Cardiovascular diseases (CVD) are the leading cause of mortality worldwide despite an
aggressive reduction of traditional cardiovascular risk factors. Underlying inflammatory
conditions such as inflammatory bowel disease (IBD) increase the risk of developing CVD. A
broad understanding of the underlying pathophysiological processes between IBD and CVD
is required to treat and prevent cardiovascular events in patients with IBD. This review
highlights the commonality between IBD and CVD, including dysregulated immune …